| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 200.49B | 196.69B | 174.34B | 162.69B | 138.41B | 110.44B |
| Gross Profit | 93.61B | 92.40B | 79.28B | 72.70B | 55.37B | 42.89B |
| EBITDA | 32.13B | 30.26B | 34.31B | 28.71B | 18.48B | 9.44B |
| Net Income | 19.46B | 18.69B | 21.70B | 17.83B | 12.28B | 3.75B |
Balance Sheet | ||||||
| Total Assets | 220.17B | 222.49B | 230.21B | 199.28B | 189.56B | 146.39B |
| Cash, Cash Equivalents and Short-Term Investments | 40.76B | 36.14B | 31.50B | 34.25B | 44.23B | 15.38B |
| Total Debt | 6.17B | 9.28B | 15.78B | 12.48B | 17.11B | 33.34B |
| Total Liabilities | 82.70B | 85.83B | 104.70B | 97.39B | 103.66B | 95.39B |
| Stockholders Equity | 137.47B | 136.65B | 125.51B | 101.89B | 85.90B | 51.00B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 20.14B | 11.83B | -3.04B | 21.09B | -3.67B |
| Operating Cash Flow | 0.00 | 23.10B | 15.30B | 3.35B | 22.60B | 3.36B |
| Investing Cash Flow | 0.00 | -855.00M | -18.03B | -5.73B | -648.00M | -6.99B |
| Financing Cash Flow | 0.00 | -17.12B | -798.00M | -8.73B | 5.52B | 3.29B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | $575.89B | 15.27 | 11.99% | 0.74% | 8.50% | 14.06% | |
75 Outperform | $1.23T | 23.58 | 10.84% | 1.56% | 3.92% | 9.99% | |
74 Outperform | $553.22B | 37.95 | 4.19% | 2.49% | 3.97% | -41.79% | |
72 Outperform | $698.52B | 23.17 | 8.09% | 2.37% | 11.18% | -0.75% | |
70 Outperform | $720.96B | 25.82 | 14.01% | 1.11% | 19.45% | 41.03% | |
65 Neutral | ¥266.99B | 13.75 | ― | 1.96% | -0.69% | -29.88% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |
JEOL Ltd. has announced a resolution to dispose of 120,000 treasury shares as part of a stock compensation plan for its directors and executives. This move is aligned with the company’s strategy to enhance the performance-linked stock compensation system, which aims to improve the company’s medium- to long-term performance and corporate value. The disposal is expected to have minimal impact on the stock market due to the controlled release of shares.
The most recent analyst rating on (JP:6951) stock is a Buy with a Yen6300.00 price target. To see the full list of analyst forecasts on JEOL Ltd. stock, see the JP:6951 Stock Forecast page.
JEOL Ltd. announced an additional contribution to its performance-linked stock compensation system, initially introduced in 2018. This move, involving a 1,450 million yen investment, aims to continue incentivizing eligible directors and officers by acquiring company shares, thereby aligning their interests with corporate performance and enhancing stakeholder value.
The most recent analyst rating on (JP:6951) stock is a Buy with a Yen6300.00 price target. To see the full list of analyst forecasts on JEOL Ltd. stock, see the JP:6951 Stock Forecast page.
JEOL Ltd. reported a decline in its financial performance for the six months ending September 30, 2025, with net sales and profits showing a year-on-year decrease. Despite the downturn, the company maintained a strong equity-to-asset ratio, indicating financial stability. The announcement highlights challenges in the market environment but also underscores JEOL’s commitment to sustaining its market position through strategic planning and financial management.
The most recent analyst rating on (JP:6951) stock is a Buy with a Yen6300.00 price target. To see the full list of analyst forecasts on JEOL Ltd. stock, see the JP:6951 Stock Forecast page.
JEOL Ltd. has announced a strategic move to transfer its medical equipment business to a newly established subsidiary, which will then be acquired by Sysmex Corporation. This decision aims to leverage Sysmex’s strong industry presence and resources to drive sustainable growth and enhance JEOL’s corporate value through synergies in research, development, and business expansion.
The most recent analyst rating on (JP:6951) stock is a Buy with a Yen5332.00 price target. To see the full list of analyst forecasts on JEOL Ltd. stock, see the JP:6951 Stock Forecast page.